22q11 DiGeorge Syndrome prognosis

The prognosis for individuals with 22q11 DiGeorge Syndrome is significantly better today than in previous decades, with most individuals living into adulthood and leading meaningful, productive lives. While the condition is lifelong and requires multidisciplinary medical management, early intervention and proactive surveillance of cardiac, immunological, and developmental needs are the primary drivers of improved long-term outcomes.

What is the long-term outlook for 22q11 DiGeorge Syndrome?

The prognosis for 22q11 DiGeorge Syndrome is highly variable, largely depending on the severity of cardiac malformations and the degree of immune system involvement. Historically, the mortality rate was higher due to severe congenital heart defects; however, advancements in pediatric cardiac surgery and neonatal care have dramatically shifted the outlook. Today, the majority of people with 22q11 DiGeorge Syndrome reach adulthood. While many will require ongoing support for learning disabilities, speech delays, or psychiatric conditions, the focus has shifted from mere survival to maximizing the quality of life through comprehensive, lifelong care.

How does prognosis vary by severity and age?

Prognosis in 22q11 DiGeorge Syndrome is heavily influenced by the "phenotypic expression"—the specific combination of symptoms an individual displays. Infants born with critical congenital heart disease (such as Tetralogy of Fallot or interrupted aortic arch) face the most significant early risks. Conversely, those with milder presentations may not be diagnosed until late childhood or even adulthood, often when developmental or psychiatric challenges become apparent. Because 22q11 DiGeorge Syndrome is a multisystem disorder, the clinical focus often shifts with age: from managing heart and immune function in infancy, to addressing developmental and educational needs in childhood, and finally to managing mental health and metabolic concerns in adulthood.

What factors improve the quality of life?

Improving the quality of life for those with 22q11 DiGeorge Syndrome requires a proactive, multidisciplinary approach. Patients who engage with a specialized care team—including cardiologists, immunologists, endocrinologists, and psychiatrists—consistently show better outcomes. Research indicates that the following factors are critical for long-term health:

• Early Intervention: Starting speech, occupational, and physical therapy as early as possible to address developmental delays.


• Consistent Monitoring: Regular screenings for hypocalcemia (low blood calcium), which can occur at any age, and monitoring for psychiatric disorders like anxiety or schizophrenia, which have an increased prevalence in this population.


• Educational Advocacy: Implementing Individualized Education Programs (IEPs) to support unique learning profiles.


• Community Support: Connecting with the 215 members of the DiseaseMaps community to share experiences and coping strategies.

What complications should be monitored over time?

Because 22q11 DiGeorge Syndrome affects multiple body systems, individuals must be monitored for potential complications throughout their lifespan. These include, but are not limited to, autoimmune disorders, recurrent infections due to T-cell deficiency, endocrine issues like hypothyroidism, and an increased risk of early-onset psychiatric conditions. Proactive care involves routine blood work to check calcium and parathyroid hormone levels, as well as regular cardiac check-ups, even if previous surgeries were successful, to monitor for structural changes or arrhythmias.

Next steps

• Consult with a clinical geneticist to coordinate a multidisciplinary care team tailored to your specific needs.


• Join the 22q11 DiGeorge Syndrome community on DiseaseMaps.org to connect with others navigating similar health journeys.


• Maintain a comprehensive medical binder containing your cardiac history, immune status, and medication list to share with new providers.


• Schedule an annual evaluation with a psychiatrist or psychologist familiar with the neurobehavioral profile of this syndrome.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): 22q11.2 deletion syndrome


• Orphanet: DiGeorge syndrome (ORPHA:635)


• OMIM (Online Mendelian Inheritance in Man): #188400 (CATCH 22)


• The International 22q11.2 Foundation